Online citations, reference lists, and bibliographies.
← Back to Search

Discovery Of Potent, Selective, Orally Active, Nonpeptide Inhibitors Of Human Mast Cell Chymase.

M. N. Greco, M. J. Hawkins, E. T. Powell, H. Almond, Lawrence de Garavilla, J. Hall, L. Minor, Y. Wang, Thomas W Corcoran, E. Di Cera, A. M. Cantwell, S. Savvides, B. Damiano, B. Maryanoff
Published 2007 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
A series of beta-carboxamido-phosphon(in)ic acids (2) was identified as a new structural motif for obtaining potent inhibitors of human mast cell chymase. For example, 1-naphthyl derivative 5f had an IC50 value of 29 nM and (E)-styryl derivative 6g had an IC50 value of 3.5 nM. An X-ray structure for 5f.chymase revealed key interactions within the enzyme active site. Compound 5f was selective for inhibiting chymase versus eight serine proteases. Compound 6h was orally bioavailable in rats (F=39%), and orally efficacious in a hamster model of inflammation.



This paper is referenced by
10.1070/RCR4525
Phosphorylation of C-H bonds of aromatic compounds using metals and metal complexes
Yu H Budnikova (2015)
10.1016/S0959-6380(08)80007-4
Chapter 5.1 Five-membered ring systems: thiophenes and Se/Te analogues
Tomasz Janosik (2009)
10.1021/jo301552m
Comprehensive synthesis of photoreactive (3-trifluoromethyl)diazirinyl indole derivatives from 5- and 6- trifluoroacetylindoles for photoaffinity labeling.
Yuta Murai (2012)
10.1016/j.bcp.2010.06.014
Potency variation of small-molecule chymase inhibitors across species.
J. Kervinen (2010)
10.1016/J.TETLET.2012.02.111
Synthesis of 1-amino-2-vinylcyclopropane-1-phosphinates. Conversion of a phosphonate to phosphinates
Hyung-Jung Pyun (2012)
10.1016/j.intimp.2016.09.019
Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases.
Jatinder Singh (2016)
10.1021/ja5063899
UV-Photoelectron Spectroscopy of BN Indoles: Experimental and Computational Electronic Structure Analysis
A. Chrostowska (2014)
10.1021/cr2002646
Review on modern advances of chemical methods for the introduction of a phosphonic acid group.
Charles S. Demmer (2011)
10.1039/C8RA04322A
Detection of chymase activity using a specific peptide probe conjugated onto gold nanoparticles
Hui-Fang Chang (2018)
10.1016/B978-0-08-095167-6.00105-1
1.7 Stereochemical Lability in Drug Molecules: Cases Where Chirality May Not Be Critical for Drug Development
Bruce E Maryanoff (2012)
10.1016/j.pep.2014.08.005
Expression of recombinant human mast cell chymase with Asn-linked glycans in glycoengineered Pichia pastoris.
Eliot T Smith (2014)
10.1165/rcmb.2009-0324RT
Mast cell peptidases: chameleons of innate immunity and host defense.
N. Trivedi (2010)
10.1021/jo4014244
Synthesis of indole analogues of the natural schweinfurthins.
John G. Kodet (2013)
10.1038/SCIBX.2010.454
ACE in the hole
Tim Fulmer (2010)
10.1021/jm400138z
Discovery of potent, selective chymase inhibitors via fragment linking strategies.
S. J. Taylor (2013)
10.1107/S0909049513020748
Crystal structure of a complex of human chymase with its benzimidazole derived inhibitor
Yoshiyuki Matsumoto (2013)
10.1371/journal.pone.0062740
Molecular Modeling Study for Inhibition Mechanism of Human Chymase and Its Application in Inhibitor Design
M. Arooj (2013)
10.1016/J.TETLET.2008.07.077
Synthesis of indolylalkylphosphonates and 3-(1 -diphenylphosphinoalkyl) indoles by reaction of 3-(1-arylsulfonylalkyl) indoles with phosphorus derivatives
M. Petrini (2008)
10.1039/C8GC03530J
Three-component 3-(phosphoryl)methylindole synthesis from indoles, H-phosphine oxides and carbonyl compounds under metal-free conditions
Jiaoting Pan (2019)
10.1016/B978-0-12-382219-2.00590-1
Chapter 590 – Chymases
George H. Caughey (2013)
10.1515/BC.2008.138
Cleaved SLPI, a novel biomarker of chymase activity
S. M. Belkowski (2008)
10.1016/J.TET.2009.06.049
Expeditious synthesis of 2,3-dihydro-2-alkoxy-3-methylenebenzofurans from N-benzofuran-3-ylmethyl N,N,N-trialkylammonium bromides: a new approach to access the natural product, 2-hydroxy-3-methylene-6-methyl-2, 3-dihydrobenzofuran
Yuanxiang Wang (2009)
10.1371/journal.pone.0063030
A Combination of Receptor-Based Pharmacophore Modeling & QM Techniques for Identification of Human Chymase Inhibitors
M. Arooj (2013)
10.1016/j.jmgm.2019.03.011
Structure-based virtual screening for novel chymase inhibitors by in silico fragment mapping.
Shin-ichiro Ozawa (2019)
10.1074/jbc.M710502200
Guinea Pig Chymase Is Leucine-specific
G. Caughey (2008)
10.1080/13543776.2018.1531848
Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010–2018)
S. Ahmad (2018)
10.1007/7081_2015_179
Preparation, Reactivity, and Synthetic Utility of Simple Benzotriazole Derivatives
Romaric Gérardy (2015)
10.1016/j.gene.2017.01.030
Dissecting the role of mutations in chymase inhibition: Free energy and decomposition analysis.
S. Verma (2017)
10.1080/07391102.2016.1234413
Structure-based QSAR, molecule design and bioassays of protease-activated receptor 1 inhibitors
Weilong Zhong (2017)
10.3109/14756360902781512
Novel diphenyl esters of peptidyl α-aminoalkylphosphonates as inhibitors of chymotrypsin and subtilisin
Ewa Pietrusewicz (2009)
10.1016/j.bmcl.2011.04.125
Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease.
M. Clarke (2011)
10.1016/j.bmcl.2012.02.060
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
Jay M. Matthews (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar